Icahn’s Bold Play: Swaps Preferred for Common Shares in Enzon‑Viskase Merger, Boosting Stake to 6% Amid Reverse Split Shake‑Ups
Icahn’s strategic move at Viskase Holdings shows how insider buying, reverse splits, and mergers can reshape biotech value and investor outlook.
3 minutes to read